Recombinant Fibroblast Growth Factor 9 (FGF9)
GAF; HBFG9; Glia-Activating Factor; Heparin-Binding Growth Factor 9
- Product No.RPA036Ra01
- Organism SpeciesRattus norvegicus (Rat) Same name, Different species.
- All
- Human
- Mouse
- Rat
- Cavia
- Rabbit
- Simian
- Caprine
- Ovine
- Equine
- Bovine
- Porcine
- Gallus
- Canine
- Others
- Multi-species
- Pan-species
- SourceProkaryotic expression
- HostE.coli
- Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
- Subcellular Locationn/a
- Predicted Molecular Massn/a
- Accurate Molecular Massn/a(Analysis of differences refer to the manual)
- Residues & TagsN-terminal His Tag
- Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
- TraitsFreeze-dried powder
- Purity> 97%
- Isoelectric Pointn/a
- ApplicationsPositive Control; Immunogen; SDS-PAGE; WB.If bio-activity of the protein is needed, please check active protein.
- Downloadn/a
- UOM10µg50µg200µg1mg5mg
- FOBUS$ 140 For more details, please contact local distributors!US$ 350 For more details, please contact local distributors!US$ 700 For more details, please contact local distributors!US$ 2100 For more details, please contact local distributors!US$ 5250 For more details, please contact local distributors!
SEQUENCE of the Recombinant Fibroblast Growth Factor 9 (FGF9)
USAGE of the Recombinant Fibroblast Growth Factor 9 (FGF9)
Reconstitute in PBS or others.
STORAGE of the Recombinant Fibroblast Growth Factor 9 (FGF9)
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY of the Recombinant Fibroblast Growth Factor 9 (FGF9)
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
Polyacrylamide Gel Electrophoresis (PAGE) Experiment Service
INCREMENT SERVICES
Endotoxin Removal KitBCA Protein Quantification KitProtein Labeling Customized ServiceMolecular Mass Marker for ProteinRecombinant Protein Customized ServiceMonoclonal Antibody Customized ServicePolyclonal Antibody Customized ServiceProtein Activity Test Experiment ServiceImmunoprecipitation (IP) Experiment ServiceBufferEndotoxin Removal Kit IIReal Time PCR Experimental ServiceSpike RBD Protein (S-RBD)Protein GProtein A
Related products
| Catalog No. | Organism species: Rattus norvegicus (Rat) | Applications (RESEARCH USE ONLY!) |
| RPA036Ra01 | Recombinant Fibroblast Growth Factor 9 (FGF9) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA036Ra01 | Polyclonal Antibody to Fibroblast Growth Factor 9 (FGF9) | WB; IHC; ICC; IP. |
| MAA036Ra21 | Monoclonal Antibody to Fibroblast Growth Factor 9 (FGF9) | WB; IHC; ICC; IP. |
| SEA036Ra | ELISA Kit for Fibroblast Growth Factor 9 (FGF9) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCA036Ra | CLIA Kit for Fibroblast Growth Factor 9 (FGF9) | Chemiluminescent immunoassay for Antigen Detection. |
ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
>
主要是中度以上细胞免疫缺陷包括:CD4+T淋巴细胞耗竭,外周血淋巴细胞显著减少,CD4<200/μl,CD4/CD8<1.0,(正常人为1.25~2.1),迟发型变态反应皮试阴性,有丝分裂原刺激反应低下。NK细胞活性下降。
2.各种致病性感染的病原体检查
如用PCR方法检测相关病原体,恶性肿瘤的组织病理学检查。
3.HIV抗体检测
采用酶联免疫吸附法、明胶颗粒凝集试验、免疫荧光检测法、免疫印迹检测法、放射免疫沉淀法等,其中前三项常用于筛选试验,后二者用于确证试验。
4.PCR技术检测HIV病毒。
①乙型肝炎表面抗原—抗体系统(HBsAg/抗—HBs);
②乙型肝炎核心抗原—抗体系统(HBcAg/抗—HBc):
③乙型肝炎e抗原—抗体系统(HBeAg);
④乙型肝炎Dane颗粒抗原—抗体系统
⑤乙型肝炎δ抗原—抗体系统(δ/抗—δ)。
临床意义 1.HBsAg:血清中检测到HBsAg ,表示体内感染了HBV,因而是一种特异性标志。HBsAg阳性见于:①急性乙型肝炎的潜伏期或急性期(大多短期阳性);②HBV致的慢性肝病、迁延性和慢性活动性肝炎、肝炎后肝硬化或原发性肝癌等。③无症状携带者
2.抗HBs:表示曾感染过HBV,不论临床上有无肝炎症状表现,均已得到恢复,并且对HBV有一定的免疫力。
3.HBcAg与抗HBc:由于 HBcAg主要存在于肝细胞核内,并仅存在于Dane颗粒中。因此,对病人血清不能检测HBcAg,而测抗HBc。血清内抗HBc阳性反映:①新近有过HBV感染;②体内有HBV增殖;③有助于诊断急性或慢性乙型肝炎,特别是少数病例就诊时已处于急性恢复期早期,HBsAg已从血中消失,此时血中仅有抗HBc存在,因此,对恢复期患者可作病因追索。
4.HBcAg和抗HBe:HBcAg的存在常表示病人血液有感染性。 HBcAg阳性揭示病人肝脏可能有慢性损害,对预后判断有一定帮助。抗HBe阳性对病人可能有一定的保护力。展开
核心抗原由183个或185个氨基酸组成,高度磷酸化,是乙肝病毒核心颗粒的唯一结构蛋白。正由于它存在于Dane颗粒核心结构表面,被表面抗原覆盖,故不易在血循环中检出。核心抗原具有强免疫原性,可诱导很强的体液免疫和细胞免疫,刺激机体产生抗-HBc。
e抗原为可溶性蛋白质,传染性强,游离存在于血液中,虽然很早就被发现,在病理上认为是HBV复制以具有强感染性的一个指标,但其功能尚不清楚。抗-HBe的出现,是预后良好的征象。向左转|向右转
流感病毒的基因组包含________基因,其中__________蛋白可作为__________的结构基础.
我不知道第一空如何填,第二空是否应该填"HA蛋白"?第3空是否应该填"突变"?
多谢各位啊!
新年快乐!
万事如意!
所以说,感染同一种病毒,每个人识别的表位可能不一样。


